The potential for emerging therapeutic options for Clostridium difficile infection

Lignende værker

• The efficacy of thuricin CD, tigecycline, vancomycin, teicoplanin, rifampicin and nitazoxanide, independently and in paired combinations against Clostridium difficile biofilms and planktonic cells
  af: Mathur, Harsh, et al.
  Udgivet: (2016)
• Analysis of Anti-Clostridium difficile Activity of Thuricin CD, Vancomycin, Metronidazole, Ramoplanin, and Actagardine, both Singly and in Paired Combinations
  af: Mathur, Harsh, et al.
  Udgivet: (2013)
• Clostridium difficile Infection: Epidemiology, Pathogenesis, Risk Factors, and Therapeutic Options
  af: Goudarzi, Mehdi, et al.
  Udgivet: (2014)
• Clostridium difficile infection: update on emerging antibiotic treatment options and antibiotic resistance
  af: Shah, Dhara, et al.
  Udgivet: (2010)
• Bacteriophage endolysins as a potential weapon to combat Clostridioides difficile infection
  af: Mondal, Shakhinur Islam, et al.
  Udgivet: (2020)